Company news
VVT Med Inc. news in 2026
VVT Med Inc.'s news releases, calls and decks from 2026, newest first.
VVT Med Signs Poland Deal Targeting CAD$1.42 Million in Sales
November 4, 2026
VVT Med Enters Panama Market Through Trial Distribution Agreement for ScleroSafe
October 22, 2026
VVT Med Establishes Exclusive Canadian Commercial Partnership with CHS for ScleroSafe®
October 1, 2026
VVT Med Closes Second Tranche of Private Placement of Units; Over $1.8M in Total Proceeds Raised
September 10, 2026
VVT Med Advances Portugal Market Entry as Dermworks Begins ScleroSafe® Market Evaluation and Announces Corporate Updates
September 1, 2026
VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure
August 21, 2026
VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece
June 26, 2026
VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor
June 11, 2026
VVT Med Announces First Patients Treated with VVT’s ScleroSafe™ System in Italy
May 26, 2026
VVT Med Provides Update on Management Cease Trade Order
May 15, 2026
VVT Med Announces Receipt of Management Cease Trade Order
May 1, 2026
VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery
April 30, 2026
VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor
April 27, 2026
VVT Med Closes $1,065,664 First Tranche of Private Placement of Units
April 22, 2026
VVT Med Announces Application for Management Cease Trade Order
April 17, 2026
VVT Med Announces Closing of Shares for Debt Transaction
April 15, 2026
VVT Med Announces Private Placement of Units
March 18, 2026
VVT Med Announces Acceptance of Procedure Fee for ScleroSafe® in South Korea
January 13, 2026